Dolutegravir Market Report

Dolutegravir Market - Global Professional Analysis and Forecast to 2026

  • POSTDATE：Nov 23, 2019
  • PAGES：151
  • REPORT CODE：GMM390810
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The worldwide Dolutegravir market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 5.6% during the forecast period.

    This report presents the market size and development trends by detailing the Dolutegravir market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Dolutegravir market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Dolutegravir industry and will help you to build a panoramic view of the industrial development.

    Dolutegravir Market, By Type:

    • 10mg Tablets

    • 50mg Tablets

    Dolutegravir Market, By Application:

    • Prevent HIV Infection Following Potential Exposure

    • Other

    Some of the leading players are as follows:

    • Mylan

    • Aurobindo Pharma

    • ViiV Healthcare (GSK)

    • Shanghai Desano Pharmaceuticals

    • LAURUS Labs

    • Adcock Ingram Limited

    Geographically, Major regions are analyzed in details are as follows:

    • North America

    • Europe

    • Asia Pacific

    • Latin America

    • Middle East & Africa

  • Table of Contents

    1 Methodology and Scope

    • 1.1 Market Segmentation & Scope

      • 1.1.1 Technology Type

      • 1.1.2 Product

      • 1.1.3 Application

      • 1.1.4 Regional scope

      • 1.1.5 Estimates and forecast timeline

    • 1.2 Research Methodology

    • 1.3 Information Procurement

      • 1.3.1 Purchased database

      • 1.3.2 Internal database

      • 1.3.3 Secondary sources

      • 1.3.4 Primary research

      • 1.3.5 Details of primary research

    • 1.4 Information or Data Analysis

      • 1.4.1 Data analysis models

    • 1.5 Market Formulation & Validation

    • 1.6 Model Details

      • 1.6.1 Commodity flow analysis

      • 1.6.2 Volume price analysis

    • 1.7 List of Secondary Sources

    • 1.8 List of Abbreviations

    2 Executive Summary

    • 2.1 Market Outlook

    • 2.2 Segment Outlook

    3 Market Variables, Trends, & Scope

    • 3.1 Market Lineage Outlook

    • 3.1.1 Parent market outlook

      • 3.1.2 Ancillary market outlook

    • 3.2 Market Segmentation

      • 3.2.1 Analysis

    • 3.3 Market Dynamics

      • 3.3.1 Market driver analysis

      • 3.3.2 Market restraint analysis

      • 3.3.3 Industry opportunities

    • 3.4 Penetration & Growth Prospect Mapping

      • 3.4.1 Penetration & growth prospect mapping analysis

    • 3.5 Business Environment Analysis Tools

      • 3.5.1 Porter's five forces analysis

      • 3.5.2 PESTLE analysis

      • 3.5.3 Major deals & strategic alliances analysis

    4 Dolutegravir Market: Technology Type Analysis

    • 4.1 Dolutegravir Technology Type Market Share Analysis, 2018 & 2026

    • 4.2 Dolutegravir Technology Type Market: Segment Dashboard

    • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

      • 4.3.1 10mg Tablets

      • 4.3.2 50mg Tablets

    5 Dolutegravir Market: Product Analysis

    • 5.1 Dolutegravir Product Market Share Analysis, 2018 & 2026

    • 5.2 Dolutegravir Product Market: Segment Dashboard

    • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

    6 Dolutegravir Market: Application Analysis

    • 6.1 Dolutegravir Application Market Share Analysis, 2018 & 2026

    • 6.2 Dolutegravir Application Market: Segment Dashboard

    • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

      • 6.3.1 Prevent HIV Infection Following Potential Exposure

      • 6.3.2 Other

    7 Dolutegravir Market: Regional Analysis

    • 7.1 Dolutegravir Regional Market Share Analysis, 2018 & 2026

    • 7.2 Dolutegravir Regional Market: Segment Dashboard

    • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

    • 7.4 List of Players at Regional Level

      • 7.4.1 North America

      • 7.4.2 Europe

      • 7.4.3 Asia Pacific

    • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

      • 7.5.1 North America

      • 7.5.2 Europe

      • 7.5.3 Asia Pacific

      • 7.5.4 Latin America

      • 7.5.5 MEA

    • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

      • 7.6.1 North America

      • 7.6.2 Europe

      • 7.6.3 Asia Pacific

      • 7.6.4 Latin America

      • 7.6.5 Middle East & Africa

    8 Competitive Analysis

    • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

    • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

    • 8.3 Vendor Landscape

      • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

    9 Company Profiles

    • 9.1 Mylan

      • 9.1.1 Mylan Company overview

      • 9.1.2 Financial performance

      • 9.1.3 Product benchmarking

      • 9.1.4 Strategic initiatives

      • 9.1.5 SWOT analysis

    • 9.2 Aurobindo Pharma

      • 9.2.1 Aurobindo Pharma Company overview

      • 9.2.2 Financial performance

      • 9.2.3 Product benchmarking

      • 9.2.4 Strategic initiatives

      • 9.2.5 SWOT analysis

    • 9.3 ViiV Healthcare (GSK)

      • 9.3.1 ViiV Healthcare (GSK) Company overview

      • 9.3.2 Financial performance

      • 9.3.3 Product benchmarking

      • 9.3.4 Strategic initiatives

      • 9.3.5 SWOT analysis

    • 9.4 Shanghai Desano Pharmaceuticals

      • 9.4.1 Shanghai Desano Pharmaceuticals Company overview

      • 9.4.2 Financial performance

      • 9.4.3 Product benchmarking

      • 9.4.4 Strategic initiatives

      • 9.4.5 SWOT analysis

    • 9.5 LAURUS Labs

      • 9.5.1 LAURUS Labs Company overview

      • 9.5.2 Financial performance

      • 9.5.3 Product benchmarking

      • 9.5.4 Strategic initiatives

      • 9.5.5 SWOT analysis

    • 9.6 Adcock Ingram Limited

      • 9.6.1 Adcock Ingram Limited Company overview

      • 9.6.2 Financial performance

      • 9.6.3 Product benchmarking

      • 9.6.4 Strategic initiatives

      • 9.6.5 SWOT analysis

     

    The List of Tables and Figures (Totals 89 Figures and 124 Tables)

    • Figure 10mg Tablets Dolutegravir market, 2015 - 2026 (USD Million)

    • Figure 50mg Tablets Dolutegravir market, 2015 - 2026 (USD Million)

    • Figure Prevent HIV Infection Following Potential Exposure market, 2015 - 2026 (USD Million)

    • Figure Other market, 2015 - 2026 (USD Million)

    • Table List of players in North America

    • Table List of players in Europe

    • Table List of players in Asia Pacific

    • Table SWOT analysis

    • Table North America Dolutegravir market, by country, 2015 - 2026 (USD Million)

    • Table North America Dolutegravir market, by type, 2015 - 2026 (USD Million)

    • Table North America Dolutegravir market, by product, 2015 - 2026 (USD Million)

    • Table North America Dolutegravir market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table U.S. Dolutegravir market, by type, 2015 - 2026 (USD Million)

    • Table U.S. Dolutegravir market, by product, 2015 - 2026 (USD Million)

    • Table U.S. Dolutegravir market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Canada Dolutegravir market, by type, 2015 - 2026 (USD Million)

    • Table Canada Dolutegravir market, by product, 2015 - 2026 (USD Million)

    • Table Canada Dolutegravir market, by application, 2015 - 2026 (USD Million)

    • Table Europe Dolutegravir market, by country, 2015 - 2026 (USD Million)

    • Table Europe Dolutegravir market, by type, 2015 - 2026 (USD Million)

    • Table Europe Dolutegravir market, by product, 2015 - 2026 (USD Million)

    • Table Europe Dolutegravir market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table U.K. Dolutegravir market, by type, 2015 - 2026 (USD Million)

    • Table U.K. Dolutegravir market, by product, 2015 - 2026 (USD Million)

    • Table U.K. Dolutegravir market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Germany Dolutegravir market, by type, 2015 - 2026 (USD Million)

    • Table Germany Dolutegravir market, by product, 2015 - 2026 (USD Million)

    • Table Germany Dolutegravir market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table France Dolutegravir market, by type, 2015 - 2026 (USD Million)

    • Table France Dolutegravir market, by product, 2015 - 2026 (USD Million)

    • Table France Dolutegravir market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Italy Dolutegravir market, by type, 2015 - 2026 (USD Million)

    • Table Italy Dolutegravir market, by product, 2015 - 2026 (USD Million)

    • Table Italy Dolutegravir market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Spain Dolutegravir market, by type, 2015 - 2026 (USD Million)

    • Table Spain Dolutegravir market, by product, 2015 - 2026 (USD Million)

    • Table Spain Dolutegravir market, by application, 2015 - 2026 (USD Million)

    • Table Asia Pacific Dolutegravir market, by country, 2015 - 2026 (USD Million)

    • Table Asia Pacific Dolutegravir market, by type, 2015 - 2026 (USD Million)

    • Table Asia Pacific Dolutegravir market, by product, 2015 - 2026 (USD Million)

    • Table Asia Pacific Dolutegravir market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table China Dolutegravir market, by type, 2015 - 2026 (USD Million)

    • Table China Dolutegravir market, by product, 2015 - 2026 (USD Million)

    • Table China Dolutegravir market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Japan Dolutegravir market, by type, 2015 - 2026 (USD Million)

    • Table Japan Dolutegravir market, by product, 2015 - 2026 (USD Million)

    • Table Japan Dolutegravir market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table India Dolutegravir market, by type, 2015 - 2026 (USD Million)

    • Table India Dolutegravir market, by product, 2015 - 2026 (USD Million)

    • Table India Dolutegravir market, by application, 2015 - 2026 (USD Million)

    • Table Latin America Dolutegravir market, by country, 2015 - 2026 (USD Million)

    • Table Latin America Dolutegravir market, by type, 2015 - 2026 (USD Million)

    • Table Latin America Dolutegravir market, by product, 2015 - 2026 (USD Million)

    • Table Latin America Dolutegravir market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Brazil Dolutegravir market, by type, 2015 - 2026 (USD Million)

    • Table Brazil Dolutegravir market, by product, 2015 - 2026 (USD Million)

    • Table Brazil Dolutegravir market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Mexico Dolutegravir market, by type, 2015 - 2026 (USD Million)

    • Table Mexico Dolutegravir market, by product, 2015 - 2026 (USD Million)

    • Table Mexico Dolutegravir market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Argentina Dolutegravir market, by type, 2015 - 2026 (USD Million)

    • Table Argentina Dolutegravir market, by product, 2015 - 2026 (USD Million)

    • Table Argentina Dolutegravir market, by application, 2015 - 2026 (USD Million)

    • Table MEA Dolutegravir market, by country, 2015 - 2026 (USD Million)

    • Table MEA Dolutegravir market, by type, 2015 - 2026 (USD Million)

    • Table MEA Dolutegravir market, by product, 2015 - 2026 (USD Million)

    • Table MEA Dolutegravir market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table South Africa Dolutegravir market, by type, 2015 - 2026 (USD Million)

    • Table South Africa Dolutegravir market, by product, 2015 - 2026 (USD Million)

    • Table South Africa Dolutegravir market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Nigeria Dolutegravir market, by type, 2015 - 2026 (USD Million)

    • Table Nigeria Dolutegravir market, by product, 2015 - 2026 (USD Million)

    • Table Nigeria Dolutegravir market, by application, 2015 - 2026 (USD Million)

    • Table Recent Developments & Impact Analysis, by Key Market Participants

    • Table Recent Developments & Impact Analysis, by Key Market Participants

    • Table Company market position analysis

    • Table Company Profiles

    • Table Mylan Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Aurobindo Pharma Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table ViiV Healthcare (GSK) Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Shanghai Desano Pharmaceuticals Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table LAURUS Labs Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Adcock Ingram Limited Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US